EMDR clinical practice

EMDR Phase 8 reevaluation and outcome monitoring between sessions

A professional framework for Phase 8 reevaluation covering prior targets, between-session material, symptoms, function, adverse events, new targets, and treatment planning.

Updated August 29, 20269 min read
EMDRSuite therapist software shown in an educational guide
Educational content only. EMDRSuite is software for qualified professionals and does not replace EMDR training, supervision, clinical judgment, emergency planning, or legal compliance review.

By the EMDRSuite Editorial Team

Product claims checked against the current EMDRSuite code and interface.

No independent clinical reviewer is named for this guide.

Editorial policy

Reevaluation is broader than reopening the last score

Phase 8 reviews what happened after the previous session and what the prior target evokes now. It considers residual disturbance, the positive cognition, bodily response, spontaneous associations, dreams, triggers, changes in symptoms and functioning, and any new clinically relevant material.

A single SUD value or a brief recap cannot represent this review. The therapist also checks current safety, consent, readiness, medication or life changes, adverse events, and whether circumstances alter the treatment plan before resuming processing.

Between-session information can change the formulation

Improvement, worsening, avoidance, new memories, current triggers, future concerns, or unexpected consequences may alter priority and sequencing. The last open target is not automatically the next target, and software should not rank material or decide whether a prior target needs more work.

Reevaluation distinguishes patient report, observable change, standardized measure results, and therapist interpretation. It also checks whether gains generalize beyond the session to sleep, relationships, work, daily functioning, and the situations named in the treatment plan.

Outcome measures complement clinical review

Validated diagnosis-specific measures can make change and deterioration easier to detect over time when used at appropriate intervals. They do not replace a clinical interview, risk assessment, adverse-event review, or the phase-specific examination of the prior target.

Measure selection, timing, interpretation, language validity, and response to deterioration remain professional responsibilities. Missing data and score changes require context; neither improvement nor a low symptom total proves that all target networks or future challenges have been addressed.

The result is a revisable treatment decision

Document the prior target's current status, between-session material, symptoms and function, safety and adverse events, measures used, present triggers, anticipated future challenges, and the rationale to continue, change focus, prepare, refer, or close treatment.

EMDRSuite can organize longitudinal notes and therapist-entered ratings. It does not conduct Phase 8, select outcome measures, infer deterioration, recommend the next target, or replace training, supervision, and clinical accountability.

EMDR outcome measures

A five-domain outcome-monitoring matrix for Phase 8

Use comparable information over time without collapsing target response, symptoms, functioning, safety, and treatment decisions into one score.

Target-level response

What it tracks

Current response to the previously selected memory, including contextual SUD, VOC, body response, triggers, and between-session material when clinically elicited.

How it informs review

Supports the Phase 8 target recheck and whether the existing formulation still fits.

What it cannot establish

SUD or VOC alone is not a diagnosis, broad outcome measure, safety assessment, or completion rule.

Standardized symptoms

What it tracks

A validated measure matched to the presentation, purpose, population, language, and interval. The PCL-5 is one official PTSD symptom example, not a universal EMDR battery.

How it informs review

Makes comparable symptom change or possible deterioration easier to discuss across planned time points.

What it cannot establish

A self-report score does not replace diagnostic interview, interpretation, patient context, or clinical judgment.

Function and personal goals

What it tracks

Participation, daily activities, relationships, work or study, and the specific change the patient identified. WHODAS 2.0 is one official generic functioning framework.

How it informs review

Tests whether change generalizes beyond the therapy room and toward the agreed treatment goals.

What it cannot establish

Symptom improvement does not automatically establish functional recovery or achievement of an individual goal.

Safety and adverse response

What it tracks

Current risk, adverse effects, destabilization, new danger, medication or health changes, and other context requiring a separate competent assessment.

How it informs review

Can change pacing, preparation, consultation, referral, contingency planning, or whether processing continues.

What it cannot establish

Safety cannot be inferred from a symptom total, a low SUD, silence between sessions, or software analytics.

Course and shared review

What it tracks

Baseline, comparable review points, missing data, patient preference, observed change, therapist interpretation, and the dated treatment-plan decision.

How it informs review

Keeps the rationale visible when continuing, changing focus, preparing, referring, or ending treatment.

What it cannot establish

No dashboard or automatic threshold selects the next target or determines that treatment is complete.

Choose, administer, license, score, and interpret any instrument according to its official instructions and your professional and local requirements. EMDRSuite does not select measures or make clinical decisions.

FAQ

EMDR outcome measures

Is Phase 8 just a SUD check?

No. It reviews the previous target, between-session experience, current symptoms and function, safety, new material, and implications for the treatment plan.

Must the previous target always continue?

No. Reevaluation determines its current status and whether new clinical information changes preparation, priority, referral, or sequencing.

Can questionnaires replace Phase 8?

No. Validated measures can complement monitoring but do not replace target-specific review, clinical interview, risk assessment, or judgment.

Does EMDRSuite recommend the next target?

No. It supports records and continuity while target choice and treatment decisions remain with the qualified therapist.